Evaluation of biochemical markers of myocardial lession after radiofrequency catheter ablation. Usefulness of cardiac troponin I;Evaluación de marcadores de lesión miocárdica tras la ablación con radiofrecuencia. Utilidad de la troponina I

Revista Espanola de Cardiologia

Volumn 50, Issue 8, 1997, Pages 552-560

  Del Rey, José Manuel ^a   Madrid, Antonio H ^b   Novo, Luis ^b   Sánchez, Andrés ^b   Martín, Jesús ^b   Rubí, José ^a   Pallarés, Esperanza ^a   Kais, Jaime ^b   Villa, Bernardo G ^b   Manzano, Juan G ^b   Silvestre, Isabel ^b   Jiménez, Adoración ^b   Ripoll, Eduardo ^a   Moro, Concepción ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TROPONIN I;

ADULT; AGED; ARTICLE; BLOOD; CARDIOMYOPATHY; CATHETER ABLATION; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; REENTRY TACHYCARDIA;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TROPONIN I;

EID: 0031202386     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(97)73263-9     Document Type: Article

References (17)

1. Ravkilde J, Nissen H, Horder M, Thygesen K. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. J Am Coll Cardiol 1995; 25: 574-581.
2. Adams III J, Bodor G, Dávila V, Delmez J, Apple F, Ladenson J et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88: 101-106.
3. Hamm CW, Ravkilde J, Gerhardt W, Jorgensen PJ, Peheim E, Katus HA. The prognostic value of serum Troponin T in unstable angina. N Engl J Med 1992; 327: 146-150.
4. Hillis WS, Birnie D, Cocherty A. Troponin T and myocardial damage. Br J Cardiol 1993; 1: 16-21.
5. Karim A, Shinn M, Oskarsson H, Windle J, Deligonul U. Significance of cardiac troponin T release after percutaneous trasluminal coronary angioplasty. Am J Cardiol 1995; 76: 521-523.
6. Cummins B, Auckland M, Cummins P. Cardiac-specific troponin-I radioinmunoassay in the diagnosis of acute myocardial infarction. Am Heart 1987; 113: 1.333-1.344.
7. Hanley J, McNeil B. A method of comparing the areas under receiver operating characteristics curves derived from the same cases. Radiology 1983; 148: 839-843.
8. Katus HA, Scheffold T, Remppis A, Sehlein J. Proteins of the troponin complex. Lab Med 1992; 23: 311-317.
9. Wilkinson JM, Grand RJA Comparison of aminoacid sequence of troponin I from different striated muscles. Nature 1987; 271: 31-35.
10. Katus H, Simon M, Zom M, Scheffold T, Remppis A, Zehelein J et al. Cardiac troponin T measurement are highly specific for myocardial cell damage [resumen]. J Am Coll Cardiol 1993; 21: (88A): 833.
11. Mair J, Wholfarter T, Koller A, Mayr M, Artner E, Puschendorf B. Serum cardiac troponin T after extraordinary endurance exercise. N Engl J Med 1992; 340: 1.048.
12. Katus H, Remmpis A, Neumann F, Scheffold T, Diederich K, Vinar G et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902-912.
13. Haines DE, Whayne J, Waker J, Nath S, Bruns D. The effect of radiofrequency catheter ablation on myocardial creatine kinase activity. J Cardiovasc Electrophysiol 1995; 6: 79-88.
14. Haines D, Verow A. Observations on electrode-tissue interface temperature and effect on electrical impedance during radiofrequency ablation of ventricular myocardium. Circulation 1990; 82: 1.034-1.038.
15. Witttkampf F, Hauer R. Robles de Medina E. Control of radiofrequency lesion size by power regulation. Circulation 1989; 80: 962-968.
16. Lüscher M, Ravkilde J, Thygesen K, Heickendorff L, and the TRIM Study Group. Troponin T and Troponin I in detection of myocardial damage and subsequent cardiac events in 516 consecutive chest pain patients. A sub-study in the TRIM study [resumen]. Eur Heart J 1996; 17: 256.
17. Lindahl B, Toss H, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic therapy [resumen]. Eur Heart J 1996; 17: 255.